Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8643
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2023 AND VI 50 AND IP 5
Results: 15
1
2
Unrevealed roles of extracellular enolase‑1 (ENO1) in promoting glycolysis and pro‑cancer activities in multiple myeloma via hypoxia‑inducible factor 1α.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8642
- By:
- Publication type:
- Article
3
RNA‑binding protein quaking 5 inhibits the progression of non‑small cell lung cancer by upregulating netrin‑4 expression.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8641
- By:
- Publication type:
- Article
4
[Retracted] MicroRNA‑381 serves as a prognostic factor and inhibits migration and invasion in non‑small cell lung cancer by targeting LRH‑1.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8640
- By:
- Publication type:
- Article
5
Targeting TRIP13 for overcoming anticancer drug resistance (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8639
- By:
- Publication type:
- Article
6
Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8638
- By:
- Publication type:
- Article
7
Differential response of MDA‑MB‑231 breast cancer and MCF10A normal breast cells to cytoskeletal disruption.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8637
- By:
- Publication type:
- Article
8
Application of artificial intelligence in colorectal cancer screening by colonoscopy: Future prospects (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8636
- By:
- Publication type:
- Article
9
Recent advances and pathological mechanisms in photodynamic and sonodynamic therapy in the treatment of bone tumors (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8635
- By:
- Publication type:
- Article
10
[Retracted] miR‑206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8634
- By:
- Publication type:
- Article
11
Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8633
- By:
- Publication type:
- Article
12
[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8632
- By:
- Publication type:
- Article
13
Extracellular vesicle‑mediated RNA editing may underlie the heterogeneity and spread of hepatocellular carcinoma in human tissue and in vitro.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8631
- By:
- Publication type:
- Article
14
Pseudolaric acid B induces apoptosis associated with the mitochondrial and PI3K/AKT/mTOR pathways in triple‑negative breast cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8630
- By:
- Publication type:
- Article
15
Circular RNA circBLNK promotes osteosarcoma progression and inhibits ferroptosis in osteosarcoma cells by sponging miR‑188‑3p and regulating GPX4 expression.
- Published in:
- Oncology Reports, 2023, v. 50, n. 5, p. N.PAG, doi. 10.3892/or.2023.8629
- By:
- Publication type:
- Article